[External validation of the University of Los Angeles Integrated Staging System (UISS) in localized renal cell carcinoma: single center study]

Date publication

janvier 2010

Auteurs

Membres identifiés du Cancéropôle Est :
Pr JACQMIN Didier , Pr LANG Hervé

Tous les auteurs :
Onea C, Mouracade P, Roman H, Wagner B, Saussine C, Jacqmin D, Lang H

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/20123526

Résumé

OBJECTIVE: To assess the ability of the University of Los Angeles Integrated Staging System (UISS) to stratify patients with a renal cell carcinoma (RCC) in one single French centre. PATIENTS AND METHODS: Four hundred and forty-three patients operated for a RCC in the Urological Department of Strasbourg University Hospital between January 1989 and December 2000 were classified according to the UISS, which combines TNM stage, Fuhrman grade and Eastern cooperative oncology group performance status. Two groups were created: 362 patients with localized and 81 patients with metastatic RCC. RESULTS: The UISS stratified the localized RCC into three different risk groups (p

Référence

Prog Urol. 2010 Jan;20(1):35-9